Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]

Lian Cui; Rongfen Chen; Smriti Subedi; Qian Yu; Yu Gong; Zeyu Chen; Yuling Shi

首页> 外文期刊>International immunopharmacology >Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]

【24h】

Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]

机译：“靶向IL-17和IL-23的生物学和生物学的疗效和安全性在治疗中度至重度斑块牛皮癣中的勘探：随机对照试验的系统评价和荟萃分析”[INT。免疫制冷。 62（2018）46-58]

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《International immunopharmacology》 |2018年第2018期|共1页
作者
Lian Cui; Rongfen Chen; Smriti Subedi; Qian Yu; Yu Gong; Zeyu Chen; Yuling Shi;
展开▼
作者单位

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

Department of Dermatology Shanghai Tenth People's Hospital Tongji University School of Medicine;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献

1. Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58] [J] . Lian Cui, Rongfen Chen, Smriti Subedi, International immunopharmacology . 2018,第期

机译：“靶向IL-17和IL-23的生物学和生物学的疗效和安全性在治疗中度至重度斑块牛皮癣中的勘探：随机对照试验的系统评价和荟萃分析”[INT。免疫制冷。 62（2018）46-58]
2. Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [J] . Fan Bai, Gang Gang Li, Qingmin Liu, Journal of immunology research. . 2019,第1期

机译：IL-17，IL-12/23和IL-23抑制剂Brodalumab，Secukinumab，Ixekizumab，Ustekizumab，Guselkumab，Tildrakizumab和Risankizumab的短期疗效和安全性用于治疗中度至重度斑块牛皮癣：系统审查和随机对照试验的网络荟萃分析
3. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points [J] . Puig L., Lopez A., Vilarrasa E., Journal of the European Academy of Dermatology and Venereology: JEADV . 2014,第12期

机译：生物制剂治疗中度至重度斑块状牛皮癣的功效：不同时间点的随机对照试验的系统评价和荟萃分析
4. Stroke unit of integrative medicine for post stroke comorbid anxiety and depression: A systematic review and meta-analysis of 25 randomized controlled trials [C] . Lingfeng Zeng, Changrong Meng, Zhaohui Liang, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：中风后合并焦虑和抑郁的中西医结合卒中科：25项随机对照试验的系统评价和荟萃分析
5. The Effects of Yoga on Cognitive Function in Neuropsychiatric Disorders: A Systematic Review and Meta-analysis of Randomized Controlled Trials [D] . Johnson, Tessa C. 2018

机译：瑜伽对神经精神障碍认知功能的影响：随机对照试验的系统评价与荟萃分析
6. Short-Term Efficacy and Safety of IL-17 IL-12/23 and IL-23 Inhibitors Brodalumab Secukinumab Ixekizumab Ustekinumab Guselkumab Tildrakizumab and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [O] . Fan Bai, Gang Gang Li, Qingmin Liu, 2019

机译：IL-17IL-12 / 23和IL-23抑制剂BrodalumabSecukinumabIxekizumabUstekinumabGuselkumabTildrakizumab和Risankizumab治疗中度至重度斑块状牛皮癣的短期疗效和安全性：系统评价和随机对照试验的网络元分析
7. Short-Term Efficacy and Safety of IL-17, IL-12/23, and IL-23 Inhibitors Brodalumab, Secukinumab, Ixekizumab, Ustekinumab, Guselkumab, Tildrakizumab, and Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials [O] . Fan Bai, Gang Gang Li, Qingmin Liu, 2019

机译：IL-17，IL-12/23和IL-23抑制剂Brodalumab，Secukinumab，Ixekizumab，Ustekizumab，Guselkumab，Tildrakizumab和Risankizumab的短期疗效和安全性用于治疗中度至重度斑块牛皮癣：系统审查和随机对照试验的网络荟萃分析

Corrigendum to “Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials” [Int. Immunopharmacol. 62 (2018) 46–58]

著录项

引文网络

相似文献

相关主题

期刊订阅